Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study

Ron Ram, Ronen Ben‐Ami, Chen Karni et al.|Transplantation and Cellular Therapy|2021

Cited by 164